Parkinson’s disease affects more than 1.1 million people in the U.S., according to the Parkinson’s Foundation.

For decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives the disease’s hallmark motor symptoms. But while therapies such as levodopa ...

PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson's disease (PD) and may avoid complications ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson's disease treatments. Published in Nature ...

The disease, which affects 1.5 million people in the U.S., is characterized by tremors, rigid posture, loss of balance, and ...

April is Parkinson’s Awareness Month. Some people may be asking what Parkinson’s disease is, while others already have a very intimate knowledge and are dealing with the disease every day. According ...

A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes in neurons – and how this can be repaired with simple delivery of energy (ATP). Parkinson’s ...

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although ...

Higa adds that there are an estimated 8,000 people in Hawaii with Parkinson's disease, although there is a belief that this ...

A new nasal spray treatment being developed by FIU researchers could slow Parkinson's disease progression, offering hope for a major shift beyond symptom management.